Digoxin
Digoxin is used for treating heart failure and slowing the heart rate in patients with chronic atrial fibrillation, a type of abnormal heart rhythm.
| Product dosage: 0.25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.53 | $48.00 (0%) | 🛒 Add to cart |
| 120 | $0.49 | $64.00 $59.00 (8%) | 🛒 Add to cart |
| 180 | $0.46 | $96.00 $83.00 (14%) | 🛒 Add to cart |
| 270 | $0.43 | $144.00 $117.00 (19%) | 🛒 Add to cart |
| 360 | $0.42
Best per pill | $192.00 $152.00 (21%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Aciphex: Advanced Acid Control for GERD Relief
Aciphex (rabeprazole sodium) is a proton pump inhibitor (PPI) designed for the effective, long-term management of gastroesophageal reflux disease (GERD) and associated conditions. By targeting the proton pumps in the stomach lining, it provides sustained reduction of gastric acid production, facilitating mucosal healing and symptom relief. This prescription medication is formulated for patients requiring consistent acid suppression, offering a clinically proven option for both short-term symptomatic control and maintenance therapy in moderate to severe cases.
Allegra: Advanced Relief for Seasonal Allergy Symptoms
Allegra (fexofenadine hydrochloride) is a leading second-generation antihistamine specifically formulated to provide non-drowsy relief from seasonal allergic rhinitis symptoms. Developed through rigorous clinical research, it represents a significant advancement in histamine H₁-receptor antagonist therapy. Its unique pharmacokinetic profile ensures targeted action without crossing the blood-brain barrier, making it a preferred choice for patients requiring alertness during treatment. Healthcare professionals widely recommend Allegra for its demonstrated efficacy and favorable safety profile in managing allergic responses.
Aricept: Enhance Cognitive Function in Alzheimer's Disease
Aricept (donepezil hydrochloride) is a prescription medication specifically formulated for the treatment of dementia associated with Alzheimer’s disease. As a centrally acting reversible acetylcholinesterase inhibitor, it works by increasing the concentration of acetylcholine in the brain, a neurotransmitter critical for memory, learning, and cognitive processing. This medication is indicated for mild, moderate, and severe stages of Alzheimer’s, offering a well-established pharmacological approach to symptom management. Clinical evidence supports its role in slowing cognitive decline and improving global function, making it a cornerstone in the therapeutic strategy for this progressive neurodegenerative disorder.
Astralean: Advanced Weight Management with Clenbuterol Hydrochloride
Astralean represents a specialized pharmaceutical formulation designed for weight management in clinically indicated scenarios. It contains Clenbuterol Hydrochloride, a beta-2-adrenergic agonist with well-documented thermogenic and bronchodilatory properties. This medication is strictly prescription-based and intended for use under direct medical supervision to mitigate risks associated with obesity and related metabolic complications where conventional methods have proven insufficient. Its mechanism promotes lipolysis and increases basal metabolic rate, making it a potent adjunct in comprehensive weight loss protocols for eligible patients.
Avodart: Clinically Proven Dutasteride for Effective BPH Management
Avodart (dutasteride) is a prescription medication specifically formulated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. As a potent 5-alpha-reductase inhibitor, it works by targeting the hormonal pathway responsible for prostate growth, leading to a significant reduction in prostate volume. This action alleviates urinary obstructive symptoms, improves urinary flow, and reduces the risk of acute urinary retention and the need for BPH-related surgery. Its targeted mechanism offers a well-tolerated, long-term management strategy for this common condition affecting aging males.
Azulfidine: Targeted Sulfasalazine Therapy for Inflammatory Bowel Disease
Azulfidine (sulfasalazine) is a time-tested, disease-modifying anti-rheumatic drug (DMARD) and aminosalicylate agent specifically formulated for the management of chronic inflammatory conditions. With a dual mechanism of action combining anti-inflammatory and antibacterial properties, it serves as a cornerstone therapy in gastroenterology and rheumatology. This medication is engineered to deliver therapeutic effects directly to the colon, making it a first-line choice for inducing and maintaining remission in ulcerative colitis. Its established efficacy and well-documented safety profile, backed by decades of clinical use, make it a reliable option for long-term disease management under appropriate medical supervision.
Chloroquine: Effective Antimalarial and Immunomodulatory Therapy
Chloroquine phosphate is a well-established antimalarial agent with additional applications in the management of certain autoimmune conditions. As a 4-aminoquinoline compound, it demonstrates potent activity against erythrocytic forms of Plasmodium species while exhibiting immunomodulatory properties through lysosomal inhibition and cytokine modulation. This comprehensive profile examines chloroquine’s pharmacological characteristics, clinical applications, and safety considerations for healthcare professionals. Features Chemical classification: 4-Aminoquinoline compound Available formulations: Oral tablets (250 mg, 500 mg chloroquine phosphate equivalent to 150 mg, 300 mg base) Mechanism: Inhibits hemozoin polymerization in malaria parasites; alters lysosomal pH and antigen processing in autoimmune conditions Bioavailability: Rapid and nearly complete gastrointestinal absorption Half-life: Approximately 1-2 months due to extensive tissue binding Metabolism: Hepatic via cytochrome P450 system Excretion: Primarily renal (50-70%), with enterohepatic recirculation Benefits Provides rapid clinical response in acute malaria attacks through schizonticidal activity Offers causal prophylaxis against susceptible Plasmodium strains Demonstrates anti-inflammatory effects in rheumatoid arthritis and lupus erythematosus Shows potential antiviral activity against certain enveloped viruses Maintains long-lasting tissue concentrations enabling weekly dosing regimens Presents cost-effective treatment option in endemic regions Common use Chloroquine is primarily indicated for the prophylaxis and treatment of malaria caused by Plasmodium vivax, P.
Clenbuterol: A Potent Bronchodilator for Respiratory Relief
Clenbuterol hydrochloride is a potent, long-acting beta2-adrenergic receptor agonist primarily indicated for the treatment of bronchospastic conditions such as asthma and chronic obstructive pulmonary disease (COPD). It functions by selectively relaxing smooth muscle in the airways, leading to significant bronchodilation and improved pulmonary function. While its primary therapeutic application is within veterinary medicine, its pharmacological profile has led to off-label interest in human athletic and bodybuilding circles, though such use is not approved and carries significant health risks.
Clenbuterol: A Selective Beta-2 Adrenergic Agonist for Respiratory Conditions
Clenbuterol hydrochloride is a selective beta-2 adrenergic receptor agonist with a well-documented pharmacological profile. Primarily developed and approved for the treatment of bronchospastic conditions such as asthma and chronic obstructive pulmonary disease (COPD), its mechanism of action involves the relaxation of bronchial smooth muscle, leading to improved airflow and bronchodilation. While its therapeutic application is specific, its pharmacological properties have attracted attention in other, non-approved contexts, necessitating a thorough, evidence-based understanding of its use, risks, and clinical protocols.